Facilitators and barriers to clinical practice guideline-consistent supportive care at pediatric oncology

Aaron J Sugalski1, Tammy Lo2, Melissa Beauchemin3

  • 1University of Texas Health Science Center at San Antonio, San Antonio, USA.

Insights

Implementing clinical practice guidelines (CPGs) in pediatric oncology is challenging. Organizational factors, including dedicated teams and prioritizing evidence-based care, are key to improving CPG implementation and patient outcomes.

Area of Science:

  • Oncology
  • Healthcare Management
  • Implementation Science

Background:

  • Clinical practice guideline (CPG)-consistent care improves patient outcomes, but implementation is often poor.
  • Limited understanding exists regarding CPG implementation within pediatric oncology settings.
  • This study focuses on supportive care CPG implementation at National Cancer Institute (NCI) Community Oncology Research Program (NCORP) institutions.

Purpose of the Study:

  • To identify facilitators and barriers to supportive care CPG implementation in pediatric oncology.
  • To understand the perspectives of healthcare professionals on CPG implementation.

Main Methods:

  • Focus groups were conducted with healthcare professionals at 26 pediatric NCORP institutions.
  • Nominal group technique (NGT) was used to identify facilitators and barriers.
  • Directed content analysis was applied to focus group notes to identify key themes.

Main Results:

  • Seven focus groups with 35 participants from 18 institutions reached saturation.
  • Top facilitators included organizational factors (e.g., charging teams), individual willingness, mentorship, implementation structure, and science-based strategies.
  • Top barriers included organizational tolerance for inconsistencies, lack of trust, administrative hurdles, lack of inclusivity, and knowledge gaps.

Conclusions:

  • Healthcare professionals identify organizational factors as crucial for supportive care CPG implementation.
  • Prioritizing evidence-based care, providing resources, and removing barriers are essential for CPG-consistent supportive care delivery.
Abstract

Related Concept Videos

Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
820
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
845
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
1.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
38
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K